A recent study in Nature Materials introduces an inhalable nanozyme treatment for viral pneumonia, showing promising results ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive interim efficacy data from the Phase I stage of its ...

The function of human airway macrophages can be therapeutically manipulated by targeting cellular metabolism to support immunity in the lung, aiding the design of innovative strategies in respiratory ...

A naturally occurring fat molecule reduced heart inflammation and scarring caused by diabetes, thereby improving cardiac ...

FSR is dedicated to accelerating sarcoidosis research through its fellowships, pilot and cardiac grants, and other ...